By inhibiting ITGB3 expression in cancer cells via infection with viral shRNA, we observed reduced migration, as expected, and increased apoptosis, but these effects were surprisingly more significant in hypoxia (Figure 5). The gene discussed is ITGB3; the disease is infection.